aRCC: 1L Treatment Options and Patient Management | VuMedi

aRCC: 1L Treatment Options and Patient Management

aRCC: 1L Treatment Options and Patient Management

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

Moffitt Cancer Center

Mechanisms of Resistance and Toxicity to Immune Checkpoint Therapy in Genitourinary Malignancies

By Moffitt Cancer Center FEATURING Jianjun Gao

By Moffitt Cancer Center FEATURING Jianjun Gao

249 views

August 25, 2022

Comments 0

Login to view comments. Click here to Login